MPMI (drug)

MPMI

Identifiers
IUPAC name 3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole
CAS Number	143321-54-4  Y 143322-55-8 (R enantiomer)
PubChem CID	53870442
ChemSpider	68007055
Chemical and physical data
Formula	C14H18N2
Molar mass	214.312 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN1CCCC1CC2=CNC3=CC=CC=C32
InChI InChI=1S/C14H18N2/c1-16-8-4-5-12(16)9-11-10-15-14-7-3-2-6-13(11)14/h2-3,6-7,10,12,15H,4-5,8-9H2,1H3 Key:HCTCDEAMCNSARD-UHFFFAOYSA-N

3-(N-methylpyrrolidin-3-ylmethyl)indole (MPMI) is a tryptamine derivative which acts as a serotonin receptor agonist. It has been studied as an analogue and trace impurity of the anti-migraine drug eletriptan but is otherwise little known. ^{[1] [2]}

See also

• α,N,N-Trimethyltryptamine
• Dimethyltryptamine
• 4-HO-MPMI
• 5F-MPMI
• 5-MeO-MPMI
• NTBT
• 10,11-Secoergoline (α,N-Pip-T)
• Pyr-T
• SN-22

References

1. FI 105812,Wythes MJ, Macor JE,"Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi",issued 14 April 1993, assigned to Pfizer, Inc. 
2. US 5607951,Macor JE, Wythes MJ,"Indole derivatives",issued 4 March 1997, assigned to Pfizer, Inc.